MegaPro Biomedical Co. Ltd.
Developing nanomedicines and drug delivery systems for oncology, hematology, and diagnostics.
TPEX
Overview
Corporate Details
- ISIN(s):
- TW0006827009
- LEI:
- Country:
- Malaysia
- Address:
- N/A
- Website:
- https://www.megaprobio.com/en/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
MegaPro Biomedical Co., Ltd. is a clinical-stage biotechnology company specializing in the development of nanomedicines. Leveraging its core technology platforms centered on nanoparticles and nano-micelles, the company engineers novel drug dosage forms and delivery systems. Its development pipeline focuses on niche indications, including oncology, hematology, and diagnostics. Key product candidates include MPB-1734, a new formulation anticancer drug; MPB-1514, a nano-iron injection for treating iron deficiency anemia; and MPB-1523, a magnetic resonance imaging (MRI) contrast agent for liver cancer detection. The company operates primarily as a research and drug application development entity.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
Automate Your Workflow. Get a real-time feed of all MegaPro Biomedical Co. Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for MegaPro Biomedical Co. Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for MegaPro Biomedical Co. Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
